Michael W. Kattan, Ph.D.
Quantitative Health Sciences /JJN3
Professor of Medicine, Epidemiology and Biostatistics, Cleveland Clinic Lerner College of Medicine
Dr. Kattan's research is primarily focused on the development, validation, and use of prediction models. Most of these models are available online, and designed for physician use, at http://rcalc.ccf.org/. He is also interested in quality of life assessment to support medical decision making (such as utility assessment), decision analysis, cost-effectiveness analysis, and comparative effectiveness.
Gerds TA, Andersen PK, Kattan MW. Calibration plots for risk prediction models in the presense of competing risks. Stat Med. 2014 Aug 15;33(18):3191-203.
Kattan MW, Yu C, Stephenson AJ, Sartor O, Tombal B. Clinicians versus nomogram: predicting future 99mTc-bone scan positivity in patients with rising prostate-specific antigen following radical prostatectomy for prostate cancer. Urology. 2013 May;81(5):956-961.
Kattan MW, Gerds TA. Stages of prediction model comparison. Eur Urol. 2012 Oct;62(4):597-599.
Kattan MW. Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets. Eur Urol. 2011 April;59(4):566-567.
Kattan MW. Doc, what are my chances? A conversation about prognostic uncertainty. Eur Urol. 2011 Feb;59(2):224.
Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010 Jan;21(1):128-138.
Kattan MW. Comparative effectiveness: a table of expected benefits and harms. Med Decis Making. 2009 Nov-Dec;29(6):NP3-NP5.